Divided Panel Upholds Patent Board In Dispute Over Cancer Treatment
WASHINGTON, D.C. — A majority of the Federal Circuit U.S. Court of Appeals on Aug. 16 confirmed findings by the Patent Trial and Appeal Board that a patented prostate cancer treatment...To view the full article, register now.
Already a subscriber? Click here to view full article